The USPTO first announced in August 2020 that it would be imposing a new fee for patent applications not filed in DOCX format beginning on January 1, 2022. After multiple extensions, the USPTO announced that the deadline is now June 30, 2023.
The USPTO recently published a final rule announcing that it would encourage the transition to filing in DOCX format by imposing new fees on certain documents submitted in a non-DOCX format. The new rule takes effect on April 3, 2023.*
The Mayo/Myriad standard arguably introduced a great deal of uncertainty into the feasibility of obtaining patent protection for life sciences innovations and has been accused of curtailing the competitiveness of U.S.-based life sciences companies in the global marketplace.